Family history and the natural history of colorectal cancer: Systematic review

Genetics in Medicine

Volumn 17, Issue 9, 2015, Pages 702-712

  Henrikson, Nora B ^a   Webber, Elizabeth M ^b   Goddard, Katrina A ^b   Scrol, Aaron ^a   Piper, Margaret ^b   Williams, Marc S ^c   Zallen, Doris T ^d   Calonge, Ned ^e   Ganiats, Theodore G ^f   Janssens, A Cecile J W ^g   Zauber, Ann ^h   Lansdorp Vogelaar, Iris ⁱ   Van Ballegooijen, Marjolein ⁱ   Whitlock, Evelyn P ^b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^e Colorado Trust ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMORY UNIVERSITY   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

colorectal cancer; family history; risk stratification; systematic review

Indexed keywords

ADENOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FAMILY HISTORY; FIRST DEGREE RELATIVE; GENETIC HETEROGENEITY; HUMAN; PATIENT COMPLIANCE; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; RISK FACTOR;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84931387300     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.188     Document Type: Review

References (69)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). http://seer. cancer. gov/csr/1975-2009- pops09/. Accessed 7 January 2014.
2. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-1674.
3. Smith RA, von Eschenbach AC, Wender R, et al.; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75; quiz 77.
4. Levin B, Rozen P, Young G. How should we follow up colorectal premalignant conditions? In: Rozen P, Young G, Levin B, Spann SJ (eds). Colorectal Cancer in Clinical Practice: Prevention, Early Detection, and Management. Martin Dunitz: London, UK, 2002:67-76.
5. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use-United States, 2012. MMWR 2013;62:881-888.
6. Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M. The Colorectal Cancer Control Program: partnering to increase population level screening. Gastrointest Endosc 2011;73:429-434.
7. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-1595.
8. American Cancer Society. Colorectal Cancer, 2014. http://www. cancer. org/ cancer/colonandrectumcancer/index. Accessed 7 January 2014.
9. American Gastroenterological Association. American Gastroenterological Association Home Page, 2014. http://www. gastro. org/. Accessed 7 January 2014.
10. Canadian Task Force on Preventive Health Care. Guidelines, 2014. http:// canadiantaskforce. ca/guidelines/. Accessed 7 January 2014.
11. US Preventive Services Task Force. Screening for Colorectal Cancer: U. S. Preventive Services Task Force Recommendation Statement. AHRQ Publication 08-05124-EF-3. 2008. http://www. uspreventiveservicestaskforce. org/uspstf08/ colocancer/colors. htm. Accessed 7 January 2014.
12. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739-750.
13. Cancer Intervention and Surveillance Modeling Network. Colorectal Cancer Model Profiles. 2014. http://cisnet. cancer. gov/colorectal/profiles. html. Accessed 7 January 2014.
14. Treadwell JR, Singh S, Talati R, McPheeters ML, Reston JT. A framework for best evidence approaches can improve the transparency of systematic reviews. J Clin Epidemiol 2012;65:1159-1162.
15. Holden DJ, Harris R, Porterfield DS, et al. Enhancing the use and quality of colorectal cancer screening. Evidence Report/Technology Assessment 2010;2010:1-195.
16. Whitlock EP, Lin JS, Chou R, Shekelle P, Robinson KA. Using existing systematic reviews in complex systematic reviews. Ann Intern Med 2008;148:776-782.
17. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000;88:2887.
18. Qureshi N, Carroll JC, Wilson B, et al. The current state of cancer family history collection tools in primary care: A systematic review. Genet Med 2009;11:495-506.
19. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Populationbased family history-specific risks for colorectal cancer: A constellation approach. Gastroenterology 2010;138:877-885.
20. Scheuner MT, McNeel TS, Freedman AN; The 2005 California Health Interview Survey. Population prevalence of familial cancer and common hereditary cancer syndromes. Genet Med 2010;12:726-735.
21. Kondo T, Toyoshima H, Tsuzuki Y, et al. Aggregation of stomach cancer history in parents and offspring in comparison with other sites. Int J Epidemiol 2003;32:579-583.
22. Pinsky PF, Kramer BS, Reding D, Buys S; PLCO Project Team. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 2003;157:792-799.
23. Sandhu MS, Luben R, Khaw KT. Prevalence and family history of colorectal cancer: Implications for screening. J Med Screen 2001;8:69-72.
24. Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C. Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol 1999;149:454-462.
25. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol 1993;10:235-244.
26. Murphy G, Shu XO, Gao YT, et al. Family cancer history affecting risk of colorectal cancer in a prospective cohort of Chinese women. Cancer Causes Control 2009;20:1517-1521.
27. Leu M, Reilly M, Czene K. Evaluation of bias in familial risk estimates: A study of common cancers using Swedish population-based registers. J Natl Cancer Inst 2008;100:1318-1325.
28. Wark PA, Wu K, van 't Veer P, Fuchs CF, Giovannucci EL. Family history of colorectal cancer: A determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer 2009;125:413-420.
29. Hoffmeister M, Schmitz S, Karmrodt E, et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol 2010;8:870-876.
30. Lynch KL, Ahnen DJ, Byers T, Weiss DG, Lieberman DA. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol 2003;1:96-102.
31. Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 2008;17:3134-3140.
32. Kao PS, Lin JK, Wang HS, et al. The impact of family history on the outcome of patients with colorectal cancer in a veterans' hospital. Int J Colorectal Dis 2009;24:1249-1254.
33. Japanese Research Society; Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum. Clinical and pathological analyses of patients with a family history of colorectal cancer. Jpn J Clin Oncol 1993;23:342-349.
34. Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Family history and survival after colorectal cancer diagnosis. Cancer 2008;112:1222-1229.
35. Chan JA, Meyerhardt JA, Niedzwiecki D, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 2008;299:2515-2523.
36. Hemminki K, Santi I, Weires M, Thomsen H, Sundquist J, Bermejo JL. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 2010;10:688.
37. Hemminki K, Granström C, Chen B. The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance. Hered Cancer Clin Pract 2005;3:7-18.
38. Townsend JS, Steele CB, Richardson LC, Stewart SL. Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med 2013;15:212-221.
39. Taylor DP, Cannon-Albright LA, Sweeney C, et al. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med 2011;13:737-743.
40. Zlot AI, Silvey K, Newell N, Coates RJ, Leman R. Family history of colorectal cancer: clinicians' preventive recommendations and patient behavior. Prev Chronic Dis 2012;9:E21.
41. Young WF, McGloin J, Zittleman L, West DR, Westfall JM. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the High Plains Research Network. J Rural Health 2007;23:238-245.
42. Peterson NB, Murff HJ, Ness RM, Dittus RS. Colorectal cancer screening among men and women in the United States. J Womens Health (Larchmt) 2007;16:57-65.
43. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U. S. population. Cancer 2004;100:2093-2103.
44. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:1623-1630.
45. Schumacher MC, Slattery ML, Lanier AP, et al. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 2008;19:725-737.
46. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med 2002;23:28-35.
47. Wong ST, Gildengorin G, Nguyen T, Mock J. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites. Cancer 2005;104(12 suppl):2940-2947.
48. Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001;91:1264-1272.
49. Zallen D. To Test or Not to Test: A Guide to Genetic Screening and Risk. Rutgers University Press: New Brunswick, NJ, 2008.
50. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis. Eur J Cancer 2006;42:216-227.
51. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003.
52. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-2385.
53. Jorde LB. Inbreeding in the Utah Mormons: An evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 1989;53(Pt 4):339-355.
54. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-857.
55. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: A systematic review. Ann Intern Med 2012;156:703-709.
56. Tuohy TM, Rowe KG, Mineau GP, Pimentel R, Burt RW, Samadder NJ. Risk of colorectal cancer and adenomas in the families of patients with adenomas: A population-based study in Utah. Cancer 2014;120:35-42.
57. Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M. Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control 2010;21:2287-2293.
58. Almendingen K, Hofstad B, Vatn MH. Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 2003;52:747-751.
59. Fossi S, Bazzoli F, Ricciardiello L, et al. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer. Am J Gastroenterol 2001;96:1601-1604.
60. National Cancer Institute. Colorectal Cancer Risk Assessment Tool. 2010. http:// www. cancer. gov/colorectalcancerrisk/. Accessed 10 December 2013.
61. Schroy PC 3rd, Coe AM, Mylvaganam SR, et al. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) 2012;5:1044-1052.
62. ClinRisk. Welcome to QCancer. 2013. http://www. qcancer. org/. Accessed 10 December 2013.
63. Yeoh KG, Ho KY, Chiu HM, et al.; Asia-Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: A validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011;60:1236-1241.
64. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-442.
65. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol 2009;170:863-872.
66. Jiao S, Peters U, Berndt S, et al. Estimating the heritability of colorectal cancer. Human Mol Genet 2014;23:3898-3905.
67. Dunlop MG, Tenesa A, Farrington SM, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut 2013;62:871-881.
68. Khoury MJ, Janssens AC, Ransohoff DF. How can polygenic inheritance be used in population screening for common diseases? Genet Med 2013;15:437-443.
69. Ghosh A, Hartge P, Kraft P, et al. Leveraging family history in population-based case-control association studies. Genet Epidemiol 2014;38:114-122.